BRD4 inhibition did not significantly affect MYC targets (NES=−1.18, p=0.30; NES=−1.15, p=0.28, Figure 2C), further confirming that BRD4 inhibition does not induce MYC suppression nor its downstream in liver cancer cell line. The gene discussed is MYC; the disease is liver cancer.